Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL

by James D’Rozario, Samuel K. Bennett
Published 2019-05-01

GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial

by Dan Dan Tian, Samuel K. Bennett, Lucy A. Coupland, Kathryn Forwood, Yadanar Lwin, Niloofar Pooryousef, Illa Tea, Thy T. Truong, Teresa Neeman, Philip Crispin, James D’Rozario, Anneke C. Blackburn
Published 2019-12-01